While reducing caspase levels in COVID-19 patients has recently been suggested as a treatment for severe COVID-19 [48], it has been demonstrated that, during fungal infection, caspase-3 inhibition limits cell apoptosis of alveolar macrophages, one of the crucial immune cells against Aspergillus infection [49]. Here, CASP3 is linked to COVID-19.